hyperbaric

Ten sessions of hyperbaric oxygen versus sham treatment in patients with long covid HOT-LoCO: a randomised, placebo-controlled, double-blind, phase II trial Anders Kjellberg; Adrian Hassler; Emil Boström; Sara El Gharbi; Sarah Al-Ezerjawi; Anna Schening; Katarina Fischer; Jan H Kowalski; Kenny A...

Abstract The SARS-CoV-2 pandemic has resulted in 762 million infections worldwide from 2020 to date, of which approximately ten percent are suffering from the effects after infection in 2019 (COVID-19) [1, 40]. In Germany, it is now assumed that at least one million people suffer from...

Abstract A potential beneficial effect of hyperbaric oxygen therapy (HBOT) on complaints of long COVID was found, leading to increased demand for this treatment despite many remaining clinical questions and lack of formal guideline recommendations and reimbursement. A registry was set up in...

Abstract Post-COVID-19 condition refers to a range of persisting physical, neurocognitive, and neuropsychological symptoms after SARS-CoV-2 infection. The mechanism can be related to brain tissue pathology caused by virus invasion or indirectly by neuroinflammation and hypercoagulability. This...

Abstract Background Long COVID is a common occurrence following COVID-19 infection. The most common symptom reported is fatigue. Limited interventional treatment options exist. We report the first evaluation of hyperbaric oxygen therapy (HBOT) for long COVID treatment. Methods A total of 10...

Source: European Underwater and Baromedical Society Date: March 1, 2019 URL: https://eubs2019.com Hyperbaric Medicine & The Brain Conference ------------------------------------------ 09-12 September 2019, Tel Aviv (...) The emerging indications related to hyperbaric oxygen and the brain...